Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis
- PMID: 33168231
- DOI: 10.1016/j.ejmech.2020.112983
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis
Abstract
This review discusses the rational for further studies of COX-2 inhibitors-NO releaser hybrids (NO-Coxibs) in the pharmacological treatment of the airway inflammation in Cystic Fibrosis (CF). Our research group developed several classes of NO-Coxibs for the pharmacological treatment of arthritis, and among them several compounds showed an outstanding in vivo efficacy and good pharmacokinetic properties. The good antiinflammatory properties displayed by these compounds during the previous screening could, by itself, suggest appropriate candidates for further testing in CF.
Keywords: CINODs; COX-2; Cystic fibrosis; Inflammation.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical
Research Materials
